These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34284482)

  • 21. Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.
    Verma P; Malhotra G; Meshram V; Chandak A; Sonavane S; Lila AR; Bandgar TR; Asopa RV
    Clin Nucl Med; 2021 Aug; 46(8):e406-e409. PubMed ID: 33883490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
    Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
    Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.
    Li Y; Zheng R; Zhang Y; Huang C; Tian L; Liu R; Liu Y; Zhang Z; Han H; Zhou F; He L; Dong P
    Int J Cancer; 2023 Jan; 152(1):42-50. PubMed ID: 35751420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
    Usmani S; Rasheed R; Al Kandari F; Ahmed N
    Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
    Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H
    Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Parghane RV; Basu S
    J Nucl Med Technol; 2023 Sep; 51(3):261-262. PubMed ID: 36041875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.
    Sadeq A; Usmani S; Esmail AA; Fathallah W; Alfeeli MA; Marafi F
    Clin Nucl Med; 2022 Jul; 47(7):627-628. PubMed ID: 35675136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery.
    Filizoglu N; Cetin IA; Kissa TN; Niftaliyeva K; Ones T
    Clin Nucl Med; 2021 Nov; 46(11):913-914. PubMed ID: 34284481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia.
    Santhosh S; Jeeva G
    Clin Nucl Med; 2021 Apr; 46(4):e190-e192. PubMed ID: 33234940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spurious Uptake on 68Ga-Prostate-Specific Membrane Antigen PET/CT Due to Ankylosing Spondylitis; A Rare Pitfall in Imaging of Biochemical Recurrence of Prostate Cancer.
    Heaney RM; Johnston C; Nasoodi A
    Clin Nucl Med; 2021 Jul; 46(7):e373-e375. PubMed ID: 33782312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of
    Raveenthiran S; Esler R; Yaxley J; Kyle S
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2280-2288. PubMed ID: 31332498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-Term Findings of Pancreatitis on 68 Ga-PSMA PET/CT in a Patient With Prostate Cancer.
    Tosunoğlu Z; Erol Fenercioğlu Ö; Beyhan E; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Dec; 47(12):e733-e734. PubMed ID: 36026591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT.
    Pernthaler B; Nazerani Hooshmand T; Igrec J; Kvaternik H; Aigner RM
    Clin Nucl Med; 2021 Apr; 46(4):e231-e232. PubMed ID: 33086280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC: Missed on 18F-FDG PET/CT.
    Jha S; Hemrom A; Shamim SA; Barwad A; Batra A
    Clin Nucl Med; 2023 Jun; 48(6):e294-e296. PubMed ID: 37133514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-Prostate-Specific Membrane Antigen PET/CT in Sinonasal Glomangiopericytoma-Exploring Theranostic Avenues!
    Sakthivel P; Kumar A; Arunraj ST; Thakur K; Jaiswal AS; Singh CA; Kumar R
    Clin Nucl Med; 2021 Apr; 46(4):340-341. PubMed ID: 33323738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer.
    Barbosa ÁRG; Amaral BS; Lourenço DB; Bianco B; Gushiken FA; Apezzato M; Silva JF; Cunha MLD; Filippi RZ; Baroni RH; Lemos GC; Carneiro A
    Einstein (Sao Paulo); 2022; 20():eAO6599. PubMed ID: 35584444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer.
    Fallahi B; Khademi N; Karamzade-Ziarati N; Fard-Esfahani A; Emami-Ardekani A; Farzanefar S; Eftekhari M; Beiki D
    Clin Nucl Med; 2021 Feb; 46(2):e68-e74. PubMed ID: 33234922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-Positive Uptake in Splenic Hemangioma on 68Ga-PSMA PET/CT Scan for Late Biochemical Recurrence of Prostate Cancer.
    Brazão ÉS; Ribeiro AMB; Lima ENP; da Costa WH; Zequi SC
    Clin Nucl Med; 2022 Jan; 47(1):e14-e16. PubMed ID: 34034314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.